Dr. Paul W Finnegan
Institution Name:
Total Awards:
2
Award Value:
$13,538,046
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Clinical Trial Stage Projects | Angiocrine Bioscience, Inc. | AB-205-301 Phase 3 Trial and Related Activities to Support Clinical Development of AB-205 | $9,740,929 |
| Late Stage Preclinical Projects | Angiocrine Bioscience, Inc. | Development of AB-110: genetically-modified endothelial cells plus expanded cord blood hematopoietic stem cells as a transplantation therapy | $3,797,117 |
| Total: $13,538,046.00 |
